1. Home
  2. SER vs GIFT Comparison

SER vs GIFT Comparison

Compare SER & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$2.81

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Logo RDE Inc.

GIFT

RDE Inc.

HOLD

Current Price

$0.86

Market Cap

39.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SER
GIFT
Founded
2017
1999
Country
United States
United States
Employees
16
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
42.0M
39.0M
IPO Year
2024
2019

Fundamental Metrics

Financial Performance
Metric
SER
GIFT
Price
$2.81
$0.86
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
40.9K
70.4K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
52.05
EPS
N/A
N/A
Revenue
$130,000.00
$83,181,716.00
Revenue This Year
N/A
$8.19
Revenue Next Year
N/A
$10.30
P/E Ratio
N/A
N/A
Revenue Growth
132.14
N/A
52 Week Low
$1.22
$0.73
52 Week High
$7.92
$1.29

Technical Indicators

Market Signals
Indicator
SER
GIFT
Relative Strength Index (RSI) 74.64 49.06
Support Level $1.74 $0.81
Resistance Level $2.99 $1.11
Average True Range (ATR) 0.16 0.07
MACD 0.07 -0.00
Stochastic Oscillator 90.91 24.11

Price Performance

Historical Comparison
SER
GIFT

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

About GIFT RDE Inc.

Giftify Inc operates in the incentive and rewards industry with a focus on retail, dining, and entertainment experiences, as the owner and operator of digital platforms, CardCash.com, Restaurant.com, and Takeout7.com. CardCash.com is a secondary gift card exchange platform, allowing consumers and retailers to buy and sell gift cards at various scales from several retailers; Restaurant.com is a restaurant-focused digital deals brand, connecting digital consumers and businesses by offering dining, retail, and entertainment deal options at several restaurants and retailers; and Takeout7 is a restaurant technology company offering online ordering solutions and AI-powered digital marketing services. Giftify has one segment, the sale of gift cards and discount certificates to its customers.

Share on Social Networks: